| 일자 | 시간 | 출처 | 헤드라인 | 심볼 | 기업 |
| 2013/03/01 | 22:49 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 2013/02/27 | 03:02 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 2013/02/15 | 00:02 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 2013/02/15 | 00:02 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 2013/02/14 | 20:08 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 2013/02/14 | 20:08 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 2013/02/12 | 22:07 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 2013/02/12 | 22:03 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 2013/02/05 | 23:01 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 2013/01/25 | 05:51 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 2013/01/24 | 07:26 | Edgar (US Regulatory) | Proxy Statement - Merger or Acquistion (definitive) (defm14a) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 2013/01/14 | 22:06 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 2013/01/14 | 22:06 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 2013/01/09 | 05:33 | Edgar (US Regulatory) | Definitive Materials Filed by Investment Companies. (497) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 2013/01/09 | 05:33 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 2013/01/09 | 05:33 | Edgar (US Regulatory) | Filing of certain prospectuses and communications in connection with business combination transactions (425) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 2013/01/09 | 03:40 | Zacks | Repligen, Pfizer Collaborate - Analyst Blog | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 2013/01/08 | 00:24 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 2013/01/08 | 00:24 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 2013/01/05 | 03:16 | Zacks | BioMimetic's Pipeline Progresses - Analyst Blog | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 2013/01/04 | 07:10 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 2013/01/04 | 07:10 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 2013/01/04 | 07:08 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 2013/01/04 | 07:08 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 2013/01/03 | 23:00 | Business Wire | BioMimetic Therapeutics, Inc. Initiates Enrollment in Augment™ Chronic Tendinopathy Clinical Trial | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 2013/01/03 | 17:14 | Zacks | Zacks #1 Rank Additions for Thursday - Tale of the Tape | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 2012/12/26 | 20:03 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 2012/12/26 | 20:03 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 2012/12/26 | 20:03 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 2012/12/26 | 20:03 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |